Statins for high cholesterol - [Medication] - Quest Diagnostics Patient Health Library Cerivastatin (Baycol) has been voluntarily taken off the market by Bayer Pharmaceutical Division because of reports that it can cause rhabdomyolysis, a severe muscle reaction that can cause death.
It's not just drug discovery that's an expensive business - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
UPDATE - It's not just drug discovery that's an expensive business - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Advances In Pharmacogenomics Projects - - - - BioNews BioWeb Companies Products BioReports - - - - - - Advances In Pharmacogenomics Projects Recent announcements by Genaissance (NASDAQ: GNSC), deCODE genetics (NASDAQ: DCGN), Pharmacia (NYSE: PHA), and Variagenics (NASDAQ: VGNX) show that the field of pharmacogenomics is advancing.
Zetia: Potential to reshape the cholesterol drug landscape? - - - - BioNews BioWeb Companies Products BioReports - - - - - Zetia: Potential to reshape the cholesterol drug landscape?
Specificity Table TOX.xls Tested (ng/ ml) BAL Dimercaprol Chelating agent 100,000 Barbitone Barbital Barbiturate 100,000 BAR 150 Baycol Cerivastatin Antihyperlipidemic 10,000 BDB BDB( d, l- 1-( 3,4- Methylenedioxyphenyl)- 2- Butanamine) MBDB metabolite 100,000 AMP 2,500 Benadryl Diphenhydramine Antihistamine/ Sedative 1,000,000 Benemid Probenecid Antigout 100,000 Bentyl Dicyclomine Anticholinergic...
author: Biosite Incorporated
Specificity Table TOX.xls page 4
author: Biosite Incorporated
pcr0404.qxd page 14
author: mcintosht
http://www.genaissance.com/investor/Genaissance_AR03.pdf page 19
author: Merrill Corporation
Drug Information This information can be used by industry as an aid in developing drug products.- Major Drug Information Pages Accutane (Isotretinoin) Information Page Alimta (pemetrexed for injection) Information Page (2/5/2004) Analgesics: Safe Use of Over-the-Counter Pain Relievers (analgesics) and Fever Reducers (antipyretics) (1/22/2004) Avastin Information Page (2/26/2004) Baycol (...
author: Carol Assouad
Drug Approvals - B NDA 21-317 10/24/01 11/6/01 2/6/02 2/6/02 Baycol (cerivastatin) Tablets, 0.4 mg, Rx Withdrawn from market 8/8/01 Bayer Corporation NDA 20-740/S-002 5/25/99 5/26/99 - 11/29/01 Baycol (cerivastatin) Tablets, Rx Withdrawn from market 8/8/01 Bayer Corporation NDA 20-740/S-003 1/4/99 - - 11/29/01 Baycol (cerivastatin) Tablets, Rx Withdrawn from market 8...
http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
1999 Warning Letters and Untitled Letters to Pharmaceutical Companies Food and Drug Administration • Center for Drug Evaluation and Research Compliance Activities Search Warning Letters and Untitled Letters to Pharmaceutical Companies 1999 These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office
V:\DAVDP\CSO\BEHR\NDA\Crimson\20685crix\SLR\slr058\dfsdocpippil\ tr.doc page 23
author: Virginia Behr
20-740S008 & S013 Baycol Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Baycol (Cerivastatin Sodium) Tablets Company:--Bayer Corporation Application No.:--20-740 Approval Date:-7/21/2000 - Approval Letter(s) - Printed Labeling - Medical Review(s) - Chemistry Review(s) - Environmental Assessment - Pharmacology Review(s) - Statistical Review(s)...
author: Paul Stauffer
Reference Listed Drug Labeling Approved in November 2000 Nov 1 DURAGESIC fentanyl transdermal system 19-813/S-026 Nov 6 BAYCOL cerivastatin Na tablets 20-740/S-014 VIRAMUNE nevirapine tablets 20-636/S-014 nevirapine oral suspension 20-933/S-003 Nov 8 METHOTREXATE methotrexate Na tablets 11-719/S-096 methotrexate Na injection 8-085/S-046 Nov 11 ZITHROMAX azithromycin for injection 50-730/S-004 azithromycin oral suspension 50-710...
author: John Grace
Office of Drug Safety Annual Report 2001 Food and Drug Administration • Center for Drug Evaluation and Research Office of Drug Safety Search Office of Drug Safety Annual Report Center for Drug Evaluation and Research Food and Drug Administration Annual Report FY 2001 EXECUTIVE SUMMARY INTRODUCTION I
author: Honig P
20-740S002_Baycol.htm Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Baycol (Cerivastatin Sodium) Tablets Company:--Bayer Corporation Application No.:--20-740S2 Approval Date:-5/24/1999 - Approval Letter(s) - Medical Review(s) - Chemistry Review(s) Pharmacology Review(s) Part 1 - Part 2 - Statistical Review(s) Clinical Pharmacology...
author: Paul Stauffer
Reference Listed Drug Labeling Approved in May 2001 May 1 FLOMAX letter label tamsulosin HCl capsules 20-579 S-007 PREVACID letter label lansoprazole delayed-release capsules 20-406 S-038 May 2 EFFEXOR EFFEXOR XR letter label venlafaxine HCl tablets venlafaxine HCl extended-release capsules 20-151 20-699 S-018 S-016 May 3 BUSPAR letter label buspirone HCl tablets 18-731 S-045 INDERIDE LA 80/50 letter label propranolol HCl/HCTZ...
author: USERNAME
Reference Listed Drug Labeling Approved in March 2001 Mar 1 LUPRON DEPOT 7.5 mg letter label leuprolide acetate for injectable suspension 19-732 S-020 LUPRON DEPOT 3.75 mg letter label leuprolide acetate for injectable suspension 20-011 S-020 LUPRON DEPOT 3 month 11.25 mg letter label leuprolide acetate for injectable suspension 20-708 S-010 LUPRON DEPOT 4 month 30 mg letter label leuprolide acetate for injectable suspension 20-517 S...
author: USERNAME
Office of Drug Safety Annual Report 2001 Back to Top Drug Withdrawals · Cerivastatin: OPDRA coordinated with the review division and shared scientific developments with our foreign regulatory counterparts regarding rhabdomyolysis associated with cerivastatin
author: Honig P
CDER Report to the Nation: 2001 Food and Drug Administration • Center for Drug Evaluation and Research About CDER - Report Search CDER Report to the Nation: 2001 Table of Contents Drug Safety and Quality Index Mission Highlights Types of Risks from Medicines Drug Safety MedWatch Outreach and Reporting Drug Shortages Cyber Letters for Foreign Ciprofloxacin Drug-induced liver injury Drug Promotion Review Drug...
author: OLIVERN
News Along the Pike, July & August 2001 Kelsey's Induction into Women's Hall of Fame Pike's Puzzler: Guess the Dates Drugs in the News: Cerivastatin withdrawn, Ribavirin Unbundled, Thyroid Hormone Transition Medical Library Launches Hot Topic InfoWebs to Keep You Up to Date Free Online Training Offers Convenient Way to Improve Skills, Knowledge Joe's Notebook: Drug Use Studied in Physician Survey Editorial Board...
author: Oliver
Baycol Information Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Baycol Information FDA announced on August 8, 2001 that Bayer Pharmaceutical Division is voluntarily withdrawing Baycol (cerivastatin) from the U.S
author: USERNAME
http://www.genaissance.com/pharmacogenomics/publications/PGS020311.pdf Oestreicher 4th Annual Pharmacogenomics and Medicine Lectures 4th Annual Pharmacogenomics and Medicine Lectures 1 3 April 2001, New Haven, Connecticut, USA Paul Oestreicher Genaissance Pharmaceuticals, Inc., Five Science Park, New Haven, CT 06511, USA In the future, pharmacogenomics will play an important role in the treatment of patients by making it possible to predict drug...
